Trial Profile
Trial of Optimal Therapy for Pseudomonas Eradication in Cystic Fibrosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Ceftazidime (Primary) ; Tobramycin (Primary) ; Ciprofloxacin
- Indications Cystic fibrosis-associated respiratory tract infections; Pseudomonal infections
- Focus Therapeutic Use
- Acronyms TORPEDO-CF
- 08 Dec 2020 This trial has been discontinued in Sweden, according to European Clinical Trials Database record.
- 06 Jul 2018 Status changed from active, no longer recruiting to completed.
- 01 Oct 2016 Status changed from recruiting to active, no longer recruiting.